Buy Target – $14.50 or better Sell Target – TradersPro Sell Signal Aravive, Inc., a clinical stage biotechnology company, focuses on developing therapies for solid tumors and hematologic malignancies. Its lead candidate is AVB-S6-500, a soluble Fc-fusion protein, which is in Phase 1b/2 clinical trials for the treatment of platinum- resistant recurrent ovarian cancer, as […]
Read MorePlus, the stocks that led the market this decade and the ones analysts are bullish on for the year ahead.
Read MoreOne of the things I love about being an investor is the opportunity to talk to other investors. It’s certainly fun to share my own ideas about successful investing and my view of current economic conditions and events, but more importantly, I really like being able to compare notes, hear their ideas, and see how […]
Read MoreBank of America is bullish on these 4 stocks heading into the new year. Here’s why.
Read More